Adlyxin vs Bydureon

Adlyxin (lixisenatide) and Bydureon (exenatide) are both injectable medications for type 2 diabetes, but they use different active ingredients made by different companies—Sanofi for Adlyxin and AstraZeneca for Bydureon. Both are taken as subcutaneous injections, meaning they’re given under the skin, but Adlyxin is a once-daily shot, while Bydureon is a once-weekly injection.

AI summary of the sources below.